Compare

Viscofan S.A./€VIS

1D1W1M3M6MYTD1Y5YMAX

About Viscofan S.A.

Viscofan S.A. operates primarily in the food industry, specializing in the production and distribution of artificial casings. These casings, made from collagen, cellulose, and other materials, are essential for meat processing and play a crucial role in sausage and processed meat manufacturing. Founded in 1975 in Spain, Viscofan has expanded its operations to include facilities and sales offices across multiple continents, enhancing its global presence. The company is headquartered in Tajonar, Spain. Viscofan's strategic advantage lies in its broad range of casing products and its extensive international network, which support its ability to meet diverse customer needs in the food industry.
Ticker
€VIS
Sector
Consumer Essentials
Primary listing
BME
Employees
5,974
Headquarters
Tajonar, Spain
Website
www.viscofan.com

Viscofan S.A. Metrics

BasicAdvanced
€2.5B
15.12
€3.58
0.15
€2.66
4.92%

What the Analysts think about Viscofan S.A.

Analyst ratings (Buy, Hold, Sell) for Viscofan S.A. stock.
Analyst projections of the future price of Viscofan S.A. stock.

Bulls say / Bears say

First-half revenue grew 4.8% on a like-for-like basis, driven by higher casing volumes, while net profit rose 2.2%. This points to resilient underlying demand despite currency effects. (Viscofan)
Capacity expansions for cellulose casings in Mexico and collagen casings in the US remain on track to serve expected demand next year. If those investments are delivered effectively, they could support further growth. (Viscofan)
Renta 4 expects third-quarter like-for-like sales growth above 7%, driven by solid volumes and recent price increases, with EBITDA up 3.8% year on year. That forecast suggests pricing and volume growth may help offset cost inflation. (Renta 4)
Higher raw-material, energy and transport costs are squeezing profitability: the first-half EBITDA margin fell 2.1 percentage points to 21.4%. Management expects full-year EBITDA at the lower end of its guidance range. (Viscofan)
Currency movements remain a significant earnings risk: first-half reported EBITDA fell 7.4%, even though it grew 3.1% on a like-for-like basis. Continued adverse exchange rates could keep reported results weaker than the underlying business. (Viscofan)
Net bank debt rose to €283.3 million from €206.1 million at year-end, with the increase including cash outflows for share buybacks and the cash dividend. Higher debt leaves less room to absorb setbacks while the company funds its expansion plans. (Viscofan)
Data summarised monthly by Lightyear AI. Last updated on 19 Oct 2026.

Viscofan S.A. Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Viscofan S.A. Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing Viscofan S.A.

AllUSDEURGBP
Funds
Fund name
Fund size
€VIS weighting
iShares Agribusiness$ISAG
$494M0.57%
iShares Agribusiness£SPAG
$494M0.57%
iShares Agribusiness€ISAE
$491M0.57%
Xtrackers Spain€XESD
€282M0.22%
Xtrackers MSCI Europe Small Cap£XXSC
$3.6B0.15%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.